Variant report
Variant | nsv668 |
---|---|
Chromosome Location | chr12:33281675-33314883 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:33287934..33289465-chr12:33290308..33292907,2 | K562 | blood: | |
2 | chr12:33276474..33280086-chr12:33280622..33283450,3 | MCF-7 | breast: | |
3 | chr12:33282689..33284420-chr12:33286427..33288390,2 | MCF-7 | breast: | |
4 | chr12:33287934..33289465-chr12:33290308..33292907,2 | K562 | blood: | |
5 | chr12:33282689..33284420-chr12:33286427..33288390,2 | MCF-7 | breast: | |
6 | chr12:33275813..33277341-chr12:33279661..33282309,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550209281 | chr12:33286670-33286671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11449896 | chr12:33286679-33286680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs397761200 | chr12:33286684-33286685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574349351 | chr12:33286694-33286695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10844480 | chr12:33286695-33286696 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs142040145 | chr12:33286710-33286711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563108658 | chr12:33286714-33286715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs117672147 | chr12:33286731-33286732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545565286 | chr12:33286749-33286750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541795972 | chr12:33286791-33286792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559438767 | chr12:33286800-33286801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183249695 | chr12:33286820-33286821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201684344 | chr12:33286830-33286831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556490611 | chr12:33286835-33286836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35135715 | chr12:33286844-33286845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187908524 | chr12:33286870-33286871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531197613 | chr12:33286897-33286898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551280621 | chr12:33286979-33286980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs145867190 | chr12:33292003-33292004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73098675 | chr12:33292039-33292040 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs538938926 | chr12:33292056-33292057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183509485 | chr12:33292115-33292116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559324693 | chr12:33292117-33292118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187764356 | chr12:33292156-33292157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs192393736 | chr12:33292168-33292169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555003943 | chr12:33292195-33292196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574944950 | chr12:33292216-33292217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184729989 | chr12:33292218-33292219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556057646 | chr12:33292228-33292229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs55801348 | chr12:33292237-33292238 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs552761486 | chr12:33292254-33292255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544960404 | chr12:33292277-33292278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189571570 | chr12:33292300-33292301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191860338 | chr12:33292366-33292367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540579319 | chr12:33292497-33292498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7977532 | chr12:33292503-33292504 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs529722926 | chr12:33292507-33292508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184294197 | chr12:33292533-33292534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532256334 | chr12:33292538-33292539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570131550 | chr12:33292541-33292542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532701248 | chr12:33292566-33292567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528035015 | chr12:33292571-33292572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551374347 | chr12:33292572-33292573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570982292 | chr12:33292579-33292580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552909562 | chr12:33292581-33292582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566424067 | chr12:33292604-33292605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148163412 | chr12:33292623-33292624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141854883 | chr12:33292658-33292659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150192371 | chr12:33292662-33292663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189064449 | chr12:33292671-33292672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chordoma | 18071362 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 21272361 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Alcoholism | 21790672 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:33286600-33287000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr12:33292000-33293200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr12:33300600-33300800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr12:33300800-33304200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr12:33304200-33304600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr12:33305000-33306200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |